Northern California Melanoma Center Report issue

Academic/Hospital Phase 2
Founded: San Francisco CA United States (1986)

Organization Overview

First Clinical Trial
2004
NCT00350597
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Lynn E. Spitler, MD

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Melanoma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 6